V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010714 | 270006306 | 1.78 | 71.4 | Palliative (P) | 2017-10-15 | 2017-10-25 | CLADRIBINE | 02 | null | 270015097 | SCOT TRIAL |
| 270010715 | 270006307 | null | 83.6 | Palliative (P) | 2017-07-10 | 2017-08-10 | CETUXIMAB + RT | N | Y | 270015179 | CARBOPLATIN + ETOPOSIDE |
| 270010716 | 270006307 | null | 69.3 | Curative (C) | 2015-02-24 | 2015-03-04 | Carboplatin AUC 6 - 10 | N | Y | 270015179 | DOCETAXEL |
| 270010717 | 270006308 | 1.73 | 58 | Palliative (P) | 2016-04-21 | 2016-04-29 | GEMCITABINE + NAB PACLITAXEL | N | N | 270015199 | NOT MATCHED |
| 270010718 | 270006309 | 1.62 | 78.3 | Palliative (P) | 2017-10-13 | 2017-10-27 | Bevacizumab 5mg/kg | 02 | N | 270015214 | CHLORAMBUCIL |
| 270010719 | 270006310 | 1.82 | null | Curative (C) | 2017-06-07 | 2017-06-22 | GDP | N | N | 270015249 | RALTITREXED |
| 270010720 | 270006310 | 1.75 | 89.35 | Curative (C) | 2016-11-01 | 2016-11-08 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270015249 | CARBOPLATIN |
| 270010721 | 270006311 | 1.75 | 95 | Curative (C) | 2017-03-31 | 2017-03-31 | Enzalutamide | 02 | N | 270015565 | FLUOROURACIL + MITOMYCIN + RT |
| 270010722 | 270006312 | 1.57 | 84 | Palliative (P) | 2018-02-01 | 2018-02-03 | CETUXIMAB + RT | N | N | 270015709 | GEMCARBO |
| 270010723 | 270006313 | 1.57 | 65 | Curative (C) | 2014-08-08 | 2014-08-29 | Carboplatin + Docetaxel | N | N | 270015756 | CAP + RT |
| 270010724 | 270013050 | null | 68.6 | Curative (C) | null | 2018-02-05 | CVP R | N | null | 270015771 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010725 | 270006314 | 1.6 | null | Palliative (P) | 2017-03-12 | 2017-03-19 | Capecitabine (14 days)+Carboplatin | N | N | 270016014 | CARBOPLATIN |
| 270010726 | 270006315 | 1.64 | 42.7 | Palliative (P) | 2016-11-05 | 2016-11-13 | CETUXIMAB | N | N | 270016024 | CETUXIMAB + RT |
| 270010727 | 270006316 | 1.6 | null | Palliative (P) | null | 2017-09-29 | Bevacizumab + Cape + Oxali 21day | null | null | 270016059 | CARBOPLATIN + PEMETREXED |
| 270010728 | 270006316 | 1.7 | 81.8 | Adjuvant (A) | 2017-03-01 | 2017-03-12 | null | 02 | N | 270016059 | CARBOPLATIN |
| 270010729 | 270016137 | 1.87 | 93.3 | Curative (C) | 2016-01-27 | 2016-01-27 | Bevacizumab + Cape + Oxali 14day | N | N | 270016281 | CETUXIMAB + RT |
| 270010730 | 270016137 | null | null | Curative (C) | 2018-02-15 | 2018-02-20 | CARBOPLATIN + RT | N | null | 270016281 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270010731 | 270006317 | 1.63 | 68 | null | 2018-09-04 | 2018-09-07 | Cisplatin + Fluorouracil + RT 5day | N | N | 270016399 | CAPECITABINE + CARBOPLATIN |
| 270010732 | 270006318 | 1.73 | 73.7 | Curative (C) | 2015-07-09 | 2015-07-11 | Carboplatin + Pemetrexed | 2 | N | 270016865 | CARBOPLATIN + VINORELBINE |
| 270010733 | 270006319 | null | 91.5 | Neo-adjuvant (N) | 2016-02-29 | 2016-03-14 | CISPLATIN + GEMCITABINE | null | null | 270017335 | FLUOROURACIL + RT |
| 270010734 | 270006320 | null | 67.2 | Curative (C) | 2013-12-31 | 2014-01-13 | Docetaxel | N | N | 270017460 | CARBOPLATIN |
| 270010735 | 270006321 | 1.71 | 98.6 | Palliative (P) | 2015-08-08 | 2015-09-03 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | 270017515 | CETUXIMAB + IRINOTECAN + MDG |
| 270010736 | 270006321 | null | 62.5 | Neo-adjuvant (N) | 2018-04-16 | 2018-04-16 | FOXTROT TRIAL | null | N | 270017515 | CISPLATIN + VINORELBINE |
| 270010737 | 270006322 | 1.71 | 53.5 | Palliative (P) | 2015-12-01 | 2016-06-26 | Irinotecan | N | N | 270017592 | CETUXIMAB + IRINOTECAN + MDG |
| 270010738 | 270006323 | 1.8 | null | Palliative (P) | 2015-01-17 | 2015-02-19 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 270017609 | CETUXIMAB |
| 270010739 | 270006323 | 1.77 | 96.6 | Palliative (P) | 2017-02-23 | 2017-03-06 | Brentuximab Vedotin | N | N | 270017609 | VINBLASTINE |
| 270010740 | 270006324 | 1.64 | null | Palliative (P) | 2017-05-10 | 2017-05-17 | Cetuximab + Radiotherapy Load | 02 | 2 | 270017704 | CARBOPLATIN |
| 270010741 | 270006325 | 1.79 | 100.3 | null | 2014-10-23 | 2014-11-08 | Carboplatin + Vinorelbine IV | N | N | 270017728 | CETUXIMAB |
| 270010742 | 270006326 | null | 65 | Neo-adjuvant (N) | 2016-04-29 | 2016-05-01 | Bevacizumab 7.5mg/kg | 02 | N | 270017733 | PAZOPANIB |
| 270010743 | 270006327 | 1.7 | 31.7 | Palliative (P) | 2015-11-03 | 2015-11-13 | Pazopanib | 2 | N | 270017757 | CARBOPLATIN + RT |
| 270010744 | 270006328 | 1.6 | 64 | Palliative (P) | 2018-11-04 | 2018-11-04 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 270017909 | CARBOPLATIN + VINORELBINE |
| 270010745 | 270006329 | 1.7 | 48.6 | Not known (9) | 2017-10-08 | 2017-11-09 | CVP R | N | null | 270017951 | CVP |
| 270010746 | 270006330 | 0 | 56.4 | Adjuvant (A) | 2017-12-29 | 2018-01-12 | SCOT TRIAL | 02 | N | 270018066 | RALTITREXED |
| 270010747 | 270006331 | null | 89.6 | Curative (C) | 2018-02-22 | 2018-02-22 | Imatinib 400mg | N | N | 270018118 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010748 | 270006332 | 1.85 | 91 | Curative (C) | 2017-09-07 | 2017-09-07 | CETUXIMAB + RT | 2 | N | 270018146 | DOCETAXEL |
| 270010749 | 270006333 | 1.63 | 98 | null | 2018-01-15 | 2018-01-31 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | 270018199 | CAP + RT |
| 270010750 | 270006334 | 1.75 | 69.7 | Curative (C) | 2017-01-31 | 2017-01-31 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 270018293 | PEMETREXED |
| 270010751 | 270006335 | 1.82 | 112.3 | Palliative (P) | 2015-02-27 | 2015-03-05 | GEMCARBO | 2 | N | 270018326 | CISPLATIN + GEMCITABINE |
| 270010752 | 270006336 | 1.75 | null | Neo-adjuvant (N) | 2015-04-17 | 2015-04-19 | Carboplatin AUC 2 - 5 | N | Y | 270018348 | CARBOPLATIN |
| 270010753 | 270006337 | null | null | Palliative (P) | 2018-06-19 | 2018-06-27 | Capecitabine (14 day) + Irinotecan | N | null | 270018514 | CETUXIMAB + MDG |
| 270010754 | 270006338 | 1.77 | 90 | Curative (C) | 2017-08-28 | 2017-08-28 | CISPLATIN + VINORELBINE | 02 | N | 270018584 | CARBOPLATIN |
| 270010755 | 270006339 | 1.76 | 78.8 | Curative (C) | 2015-03-15 | 2016-03-25 | Pazopanib | N | N | 270018604 | GEMCARBO |
| 270010756 | 270006340 | null | null | Palliative (P) | 2016-12-02 | 2016-12-28 | Cetuximab + Radiotherapy Maint | N | N | 270018614 | SCOT TRIAL |
| 270010757 | 270006341 | 1.55 | 73 | Palliative (P) | 2013-10-01 | 2013-10-01 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270018723 | CETUXIMAB |
| 270010758 | 270006342 | null | null | Adjuvant (A) | null | 2016-07-23 | Cetuximab 14 day | N | N | 270018835 | GEMCITABINE |
| 270010759 | 270006343 | 1.72 | 130.8 | Curative (C) | 2017-07-29 | 2017-08-26 | CVP R | 01 | N | 270018870 | BCG |
| 270010760 | 270006344 | null | 0 | Adjuvant (A) | 2014-11-07 | 2014-11-23 | Bevacizumab + Capecitabine | Y | N | 270018874 | GEMCARBO |
| 270010761 | 270006345 | 1.71 | 73.8 | Not known (9) | 2015-11-26 | 2015-12-15 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270018958 | CARBOPLATIN + PACLITAXEL |
| 270010762 | 270013054 | 1.57 | 59.6 | Curative (C) | 2017-09-11 | 2017-09-24 | CAPECITABINE + MITOMYCIN + RT | 02 | null | 270019049 | OXALIPLATIN |
| 270010763 | 270006346 | 1.64 | 67.1 | Not known (9) | 2014-04-20 | 2014-05-18 | Bevacizumab + Cape + Oxali 14day | N | N | 270019084 | CETUXIMAB |